vs

Side-by-side financial comparison of FONAR CORP (FONR) and Zeo Energy Corp. (ZEO). Click either name above to swap in a different company.

FONAR CORP is the larger business by last-quarter revenue ($25.5M vs $18.6M, roughly 1.4× Zeo Energy Corp.). FONAR CORP runs the higher net margin — 8.0% vs -10.8%, a 18.9% gap on every dollar of revenue. On growth, FONAR CORP posted the faster year-over-year revenue change (2.4% vs -0.4%). Zeo Energy Corp. produced more free cash flow last quarter ($2.3M vs $-227.0K). Over the past eight quarters, FONAR CORP's revenue compounded faster (-0.3% CAGR vs -4.0%).

FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.

FONR vs ZEO — Head-to-Head

Bigger by revenue
FONR
FONR
1.4× larger
FONR
$25.5M
$18.6M
ZEO
Growing faster (revenue YoY)
FONR
FONR
+2.8% gap
FONR
2.4%
-0.4%
ZEO
Higher net margin
FONR
FONR
18.9% more per $
FONR
8.0%
-10.8%
ZEO
More free cash flow
ZEO
ZEO
$2.5M more FCF
ZEO
$2.3M
$-227.0K
FONR
Faster 2-yr revenue CAGR
FONR
FONR
Annualised
FONR
-0.3%
-4.0%
ZEO

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
FONR
FONR
ZEO
ZEO
Revenue
$25.5M
$18.6M
Net Profit
$2.1M
$-2.0M
Gross Margin
Operating Margin
13.5%
-11.8%
Net Margin
8.0%
-10.8%
Revenue YoY
2.4%
-0.4%
Net Profit YoY
4.7%
-360.9%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FONR
FONR
ZEO
ZEO
Q4 25
$25.5M
$18.6M
Q3 25
$26.0M
$23.9M
Q2 25
$27.3M
$18.1M
Q1 25
$27.2M
$8.8M
Q4 24
$24.9M
$18.6M
Q3 24
$25.0M
$19.7M
Q2 24
$25.9M
$14.8M
Q1 24
$25.7M
$20.1M
Net Profit
FONR
FONR
ZEO
ZEO
Q4 25
$2.1M
$-2.0M
Q3 25
$2.3M
$-3.2M
Q2 25
$729.3K
$-2.4M
Q1 25
$2.5M
$-6.4M
Q4 24
$2.0M
$-435.3K
Q3 24
$3.1M
$-424.3K
Q2 24
$830.4K
$-277.8K
Q1 24
$1.9M
$-1.5M
Gross Margin
FONR
FONR
ZEO
ZEO
Q4 25
Q3 25
57.9%
Q2 25
59.8%
Q1 25
99.3%
Q4 24
Q3 24
50.2%
Q2 24
52.3%
Q1 24
Operating Margin
FONR
FONR
ZEO
ZEO
Q4 25
13.5%
-11.8%
Q3 25
14.1%
-8.3%
Q2 25
5.3%
-15.8%
Q1 25
15.2%
-153.8%
Q4 24
11.9%
-6.0%
Q3 24
21.0%
-15.2%
Q2 24
7.4%
-18.0%
Q1 24
16.8%
-20.1%
Net Margin
FONR
FONR
ZEO
ZEO
Q4 25
8.0%
-10.8%
Q3 25
8.7%
-13.5%
Q2 25
2.7%
-13.3%
Q1 25
9.2%
-72.4%
Q4 24
7.9%
-2.3%
Q3 24
12.6%
-2.2%
Q2 24
3.2%
-1.9%
Q1 24
7.3%
-7.6%
EPS (diluted)
FONR
FONR
ZEO
ZEO
Q4 25
Q3 25
Q2 25
Q1 25
$-0.48
Q4 24
$1.11
Q3 24
$-0.08
Q2 24
$0.03
Q1 24
$-1.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FONR
FONR
ZEO
ZEO
Cash + ST InvestmentsLiquidity on hand
$121.0K
$6.1M
Total DebtLower is stronger
$79.1K
Stockholders' EquityBook value
$176.9M
$5.3M
Total Assets
$217.2M
$56.9M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FONR
FONR
ZEO
ZEO
Q4 25
$121.0K
$6.1M
Q3 25
$122.0K
$3.9M
Q2 25
$56.5M
$68.7K
Q1 25
$123.0K
$2.9M
Q4 24
$121.0K
$5.6M
Q3 24
$136.0K
$4.3M
Q2 24
$56.5M
$5.3M
Q1 24
$134.0K
Total Debt
FONR
FONR
ZEO
ZEO
Q4 25
$79.1K
Q3 25
$84.6K
Q2 25
$642.8K
Q1 25
$715.4K
Q4 24
$787.7K
Q3 24
$858.6K
Q2 24
$66.9K
$1.6M
Q1 24
$748.8K
Stockholders' Equity
FONR
FONR
ZEO
ZEO
Q4 25
$176.9M
$5.3M
Q3 25
$174.9M
$-1.7M
Q2 25
$172.6M
$-59.4M
Q1 25
$171.9M
$-23.1M
Q4 24
$169.8M
$-88.9M
Q3 24
$168.7M
$-39.3M
Q2 24
$166.0M
$-53.0M
Q1 24
$165.8M
$-173.0M
Total Assets
FONR
FONR
ZEO
ZEO
Q4 25
$217.2M
$56.9M
Q3 25
$218.4M
$58.5M
Q2 25
$216.9M
$46.2M
Q1 25
$214.9M
$47.4M
Q4 24
$208.0M
$61.0M
Q3 24
$212.3M
$47.1M
Q2 24
$214.2M
$49.1M
Q1 24
$209.6M
$50.1M
Debt / Equity
FONR
FONR
ZEO
ZEO
Q4 25
0.01×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.00×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FONR
FONR
ZEO
ZEO
Operating Cash FlowLast quarter
$171.0K
$2.4M
Free Cash FlowOCF − Capex
$-227.0K
$2.3M
FCF MarginFCF / Revenue
-0.9%
12.2%
Capex IntensityCapex / Revenue
1.6%
0.9%
Cash ConversionOCF / Net Profit
0.08×
TTM Free Cash FlowTrailing 4 quarters
$5.7M
$-9.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FONR
FONR
ZEO
ZEO
Q4 25
$171.0K
$2.4M
Q3 25
$1.7M
$-6.6M
Q2 25
$4.2M
$-2.3M
Q1 25
$3.1M
$-2.3M
Q4 24
$2.2M
$3.5M
Q3 24
$1.7M
$162.2K
Q2 24
$4.6M
$-2.2M
Q1 24
$2.8M
$-10.2M
Free Cash Flow
FONR
FONR
ZEO
ZEO
Q4 25
$-227.0K
$2.3M
Q3 25
$-177.0K
$-6.8M
Q2 25
$3.6M
$-2.7M
Q1 25
$2.6M
$-2.6M
Q4 24
$1.5M
$3.4M
Q3 24
$-148.0K
$116.5K
Q2 24
$4.2M
$-2.3M
Q1 24
$2.6M
$-10.4M
FCF Margin
FONR
FONR
ZEO
ZEO
Q4 25
-0.9%
12.2%
Q3 25
-0.7%
-28.6%
Q2 25
13.1%
-15.0%
Q1 25
9.4%
-30.0%
Q4 24
6.0%
18.2%
Q3 24
-0.6%
0.6%
Q2 24
16.1%
-15.6%
Q1 24
10.2%
-51.5%
Capex Intensity
FONR
FONR
ZEO
ZEO
Q4 25
1.6%
0.9%
Q3 25
7.2%
1.0%
Q2 25
2.4%
2.4%
Q1 25
2.2%
4.2%
Q4 24
3.0%
0.5%
Q3 24
7.2%
0.2%
Q2 24
1.6%
0.7%
Q1 24
0.7%
1.1%
Cash Conversion
FONR
FONR
ZEO
ZEO
Q4 25
0.08×
Q3 25
0.75×
Q2 25
5.79×
Q1 25
1.26×
Q4 24
1.14×
Q3 24
0.53×
Q2 24
5.54×
Q1 24
1.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FONR
FONR

Managementof Diagnostic Imaging Centers$23.2M91%
Manufacturingand Servicingof Medical Equipment$2.4M9%

ZEO
ZEO

Nonrelated Party$18.1M98%
Related Party$432.1K2%

Related Comparisons